Oravig buccal tablets approved for oropharyngeal candidiasis - ONA
Links shared publicly online about this topic.
- 1,229total visits
Oravig buccal tablets approved for oropharyngeal candidiasis - ONA
View full resource at oncologynurseadvisor.com
Tags: Yeast Infection, Candidiasis, Vaginal Infection, FDA
Most Recently Shared on April 19, 2010 at 2:54 pm By:
Oravig buccal tablets approved for oropharyngeal candidiasis http://goo.gl/fb/6pGLC
ORAVIG - New Product Releases - MPR
empr.com — “Local treatment of oropharyngeal candidiasis.” View full resource at empr.com
Most Recently Shared on September 17, 2010 at 1:24 pm By:
MPR News: ORAVIG: Miconazole 50mg; buccal tablet. http://bit.ly/9EW5YS
FDA Approves Oravig (miconazole) Buccal Tablets for Treatment of Oropharyngeal Candidiasis
drugs.com — “Oravig (miconazole) is used to treat oropharyngeal candidiasis. Includes Oravig side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 18, 2010 at 10:24 pm By:
FDA Approves Oravig (miconazole) Buccal Tablets for Treatment of Oropharyngeal Candidiasis - http://bit.ly/8Ze2GO
FDA Approves Oravig(TM) (miconazole) Buccal Tablets For Treatment Of Oropharyngeal Candidiasis
medicalnewstoday.com — “Strativa Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Oravig (miconazole) buccal tablets for the treatment of oropharyngeal candidiasis (OPC), more commo” View full resource at medicalnewstoday.com
Most Recently Shared on April 17, 2010 at 1:05 pm By:
MNT Ear, Nose Throat Health News
FDA Approves Oravig(TM) (miconazole) Buccal Tablets For Treatment Of Oropharyngeal Candidiasis http://mnt.to/3Bpp #entnews
U.S. FDA approval of miconazole MBT represents a significant milestone for Strativa Pharmaceuticals
news-medical.net — “Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad((R)) mucoadhesive buccal tablets (MBT) to treat oropharyngeal candidiasis (OPC).” View full resource at news-medical.net
Most Recently Shared on August 19, 2009 at 2:12 pm By:
HIV/AIDS News: U.S. FDA approval of miconazole MBT represents a significant milestone for Strativa.. http://ub0.cc/kN/11
Advertisement
